Danavorexton
- Generic Name
- Danavorexton
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H32N2O5S
- CAS Number
- 2114324-48-8
- Unique Ingredient Identifier
- 1QMD83K4YN
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Takeda
- Target Recruit Count
- 41
- Registration Number
- NCT05814016
- Locations
- 🇺🇸
Helen Keller Hospital, Sheffield, Alabama, United States
🇺🇸Mayo Clinic - PPDS - Hospital, Phoenix, Arizona, United States
🇺🇸UCSD, La Jolla, California, United States
A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 13
- Registration Number
- NCT05180890
- Locations
- 🇦🇺
Adelaide Institute for Sleep Health (AISH), Flinders University, Adelaide, Australia
A Study of Danavorexton in Anesthetized Adults
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Takeda
- Target Recruit Count
- 28
- Registration Number
- NCT05025397
- Locations
- 🇺🇸
Endeavor Clinical Trials, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath